STTK
MaterialsShattuck Labs Inc
Live · NASDAQ · May 9, Close
What's Moving STTK Today?
No stock-specific AI insight has been generated for STTK yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
STTK News
20 articles- Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business HighlightsYahoo Finance·May 7, 2026
- Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK)Yahoo Finance·May 1, 2026
- Why Shattuck Labs Stock Soared More Than 53% Higher This WeekMotley Fool·Mar 6, 2026
- Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business HighlightsYahoo Finance·Mar 5, 2026
- Shattuck Labs Announces Participation in Upcoming March Investor ConferencesYahoo Finance·Feb 25, 2026
- Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology SymposiumYahoo Finance·Feb 6, 2026
- Why Shattuck Labs Stock Soared in DecemberMotley Fool·Jan 6, 2026
- Several Insiders Invested In Shattuck Labs Flagging Positive NewsYahoo Finance·Jan 5, 2026
- Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Dec 15, 2025
- Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 ResultYahoo Finance·Nov 29, 2025
- Hedge funds own 27% of Shattuck Labs, Inc. (NASDAQ:STTK) shares but individual investors control 32% of the companyYahoo Finance·Nov 25, 2025
- Shattuck Labs to Participate in Upcoming December Investor ConferencesYahoo Finance·Nov 20, 2025
- Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business HighlightsYahoo Finance·Nov 6, 2025
- What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now?Yahoo Finance·Oct 8, 2025
- Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company PanelYahoo Finance·Oct 2, 2025
- Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?Yahoo Finance·Sep 19, 2025
- Shattuck Labs (STTK) Upgraded to Buy: What Does It Mean for the Stock?Yahoo Finance·Sep 8, 2025
- Top Penny Stocks To Watch In September 2025Yahoo Finance·Sep 4, 2025
- Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of DirectorsYahoo Finance·Aug 26, 2025
- Shattuck Labs Says Investigational New Drug Application for SL-325 in EffectYahoo Finance·Aug 21, 2025
All 20 articles loaded
Price Data
Fundamentals
Trading
About Shattuck Labs Inc
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.